saf-301
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01474343)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- N-sulphoglucosamine sulphohydrolaseSupplementation
supplementation - SGSH
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- saf-301
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02053064 | Phase 1/Phase 2 (Phase 2) | May 1, 2013 | LYSOGENE |
| NCT01474343 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2011 | LYSOGENE |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LYSOGENE | For profit | 2 | 2 | 1 | 2011 |
1 organizations
Page 1 / 1